What is Chardan Capital’s Estimate for ARWR FY2025 Earnings?
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities researchers at Chardan Capital increased their FY2025 earnings estimates for Arrowhead Pharmaceuticals in a note issued to investors on Tuesday, May 13th. Chardan Capital analyst K. Nakae now anticipates that the biotechnology company will post earnings per share of ($1.27) for the year, up from their […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities researchers at Chardan Capital increased their FY2025 earnings estimates for Arrowhead Pharmaceuticals in a note issued to investors on Tuesday, May 13th. Chardan Capital analyst K. Nakae now anticipates that the biotechnology company will post earnings per share of ($1.27) for the year, up from their […]
